Rainer Gloeckl1, Tessa Schneeberger, Inga Jarosch, Klaus Kenn. 1. Schön Klinik Berchtesgadener Land, Schönau am Königssee; The Centre for Preventive and Sports Medicine, Klinikum Rechts der Isar, Technical University of; Munich (TUM); Philipps-Universität Marburg, German Center for Lung Research (DZL).
Abstract
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a common condition that is becoming increasingly prevalent. It affects 13.2% of the population over age 40 in Germany. In 2020, it will be the third most common cause of morbidity and mortality around the world. It markedly impairs the quality of life of those who suffer from it and presents a major economic challenge to the health-care system. METHODS: This review is based on pertinent publications retrieved by a selective literature search and on the authors' clinical experience. RESULTS: Pulmonary rehabilitation (PR) for patients with COPD is supported by evidence on the highest level. It is associated with statistically significant (p <0.001) and clinically relevant improvement in physical performance (6-minute walk distance: + 44 m; 95% confidence interval [33; 55]), shortness of breath (Chronic Respiratory Disease Questionnaire: +0.79 points [0.56; 1.03]), and the quality of life (Saint George´s Respiratory Questionnaire: -6.9 points [-9.3; -4.5]). The benefits of PR are especially evident after an acute exacerbation of COPD: it significantly lowers the rate of readmission to the hospital (odds ratio 0.22 [0.08; 0.58], p = 0.002) and improves physical performance ability (6-minute walk distance: + 62 m [38; 86] and the quality of life (Saint George´s Respiratory Questionnaire: -7.8 points [-12.1; -3.5]; p <0.001 for both). CONCLUSION: PR is an effective and cost-effective therapeutic intervention that improves physical performance ability, shortness of breath, and the quality of life in patients with COPD, but it has not yet been fully implemented as recommended in the relevant guidelines. There is a need for targeted, problem-oriented referral to a range of PR programs with problem-specific content. The necessary outpatient PR structures still need to be established in Germany.
BACKGROUND:Chronic obstructive pulmonary disease (COPD) is a common condition that is becoming increasingly prevalent. It affects 13.2% of the population over age 40 in Germany. In 2020, it will be the third most common cause of morbidity and mortality around the world. It markedly impairs the quality of life of those who suffer from it and presents a major economic challenge to the health-care system. METHODS: This review is based on pertinent publications retrieved by a selective literature search and on the authors' clinical experience. RESULTS: Pulmonary rehabilitation (PR) for patients with COPD is supported by evidence on the highest level. It is associated with statistically significant (p <0.001) and clinically relevant improvement in physical performance (6-minute walk distance: + 44 m; 95% confidence interval [33; 55]), shortness of breath (Chronic Respiratory Disease Questionnaire: +0.79 points [0.56; 1.03]), and the quality of life (Saint George´s Respiratory Questionnaire: -6.9 points [-9.3; -4.5]). The benefits of PR are especially evident after an acute exacerbation of COPD: it significantly lowers the rate of readmission to the hospital (odds ratio 0.22 [0.08; 0.58], p = 0.002) and improves physical performance ability (6-minute walk distance: + 62 m [38; 86] and the quality of life (Saint George´s Respiratory Questionnaire: -7.8 points [-12.1; -3.5]; p <0.001 for both). CONCLUSION: PR is an effective and cost-effective therapeutic intervention that improves physical performance ability, shortness of breath, and the quality of life in patients with COPD, but it has not yet been fully implemented as recommended in the relevant guidelines. There is a need for targeted, problem-oriented referral to a range of PR programs with problem-specific content. The necessary outpatient PR structures still need to be established in Germany.
Authors: Andrew L Ries; Gerene S Bauldoff; Brian W Carlin; Richard Casaburi; Charles F Emery; Donald A Mahler; Barry Make; Carolyn L Rochester; Richard Zuwallack; Carla Herrerias Journal: Chest Date: 2007-05 Impact factor: 9.410
Authors: J Bott; S Blumenthal; M Buxton; S Ellum; C Falconer; R Garrod; A Harvey; T Hughes; M Lincoln; C Mikelsons; C Potter; J Pryor; L Rimington; F Sinfield; C Thompson; P Vaughn; J White Journal: Thorax Date: 2009-05 Impact factor: 9.139
Authors: Annemie M W J Schols; Roelinka Broekhuizen; Clarie A Weling-Scheepers; Emiel F Wouters Journal: Am J Clin Nutr Date: 2005-07 Impact factor: 7.045
Authors: Carolyn L Rochester; Ioannis Vogiatzis; Anne E Holland; Suzanne C Lareau; Darcy D Marciniuk; Milo A Puhan; Martijn A Spruit; Sarah Masefield; Richard Casaburi; Enrico M Clini; Rebecca Crouch; Judith Garcia-Aymerich; Chris Garvey; Roger S Goldstein; Kylie Hill; Michael Morgan; Linda Nici; Fabio Pitta; Andrew L Ries; Sally J Singh; Thierry Troosters; Peter J Wijkstra; Barbara P Yawn; Richard L ZuWallack Journal: Am J Respir Crit Care Med Date: 2015-12-01 Impact factor: 21.405
Authors: Martijn A Spruit; Sally J Singh; Chris Garvey; Richard ZuWallack; Linda Nici; Carolyn Rochester; Kylie Hill; Anne E Holland; Suzanne C Lareau; William D-C Man; Fabio Pitta; Louise Sewell; Jonathan Raskin; Jean Bourbeau; Rebecca Crouch; Frits M E Franssen; Richard Casaburi; Jan H Vercoulen; Ioannis Vogiatzis; Rik Gosselink; Enrico M Clini; Tanja W Effing; François Maltais; Job van der Palen; Thierry Troosters; Daisy J A Janssen; Eileen Collins; Judith Garcia-Aymerich; Dina Brooks; Bonnie F Fahy; Milo A Puhan; Martine Hoogendoorn; Rachel Garrod; Annemie M W J Schols; Brian Carlin; Roberto Benzo; Paula Meek; Mike Morgan; Maureen P M H Rutten-van Mölken; Andrew L Ries; Barry Make; Roger S Goldstein; Claire A Dowson; Jan L Brozek; Claudio F Donner; Emiel F M Wouters Journal: Am J Respir Crit Care Med Date: 2013-10-15 Impact factor: 21.405
Authors: Celalettin Korkmaz; Soner Demirbas; Hulya Vatansev; Elif Yildirim; Turgut Teke; Adil Zamani Journal: J Int Med Res Date: 2020-04 Impact factor: 1.671
Authors: Leah B Sansbury; David A Lipson; Chanchal Bains; Glenn A Anley; Kieran J Rothnie; Afisi S Ismaila Journal: Int J Chron Obstruct Pulmon Dis Date: 2022-03-03
Authors: Martin Halle; Wilhelm Bloch; Andreas M Niess; Hans-Georg Predel; Claus Reinsberger; Jürgen Scharhag; Jürgen Steinacker; Bernd Wolfarth; Johannes Scherr; Josef Niebauer Journal: Transl Sports Med Date: 2021-05-04